Back
Dermata Therapeutics Stock Price Chart
Sponsored
DRMA
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
17
DRMA
Dermata Therapeutics
Last Price:
1.92
Seasonality Move:
-51.46%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and DRMA is experiencing slight buying pressure.
Dermata Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.81 | Buy |
20-day SMA: | 1.74 | Buy |
50-day SMA: | 2.01 | Buy |
200-day SMA: | 5.05 | Sell |
8-day EMA: | 1.91 | Buy |
20-day EMA: | 1.85 | Buy |
50-day EMA: | 2.14 | Buy |
200-day EMA: | 9.07 | Sell |
Dermata Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 58.02 | Buy |
Chaikin Money Flow: | 245155 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.55 - 2.07) | Buy |
Bollinger Bands (100): | (1.68 - 3.98) | Sell |
Dermata Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 2.25 while DRMA 8-day simple moving average is 1.81, which is a Buy signal.
- The stock price of DRMA is 2.25 while Dermata Therapeutics 20-day SMA is 1.74, which makes it a Buy.
- Dermata Therapeutics 50-day simple moving average is 2.01 while DRMA share price is 2.25, making it a Buy technically.
- DRMA stock price is 2.25 and Dermata Therapeutics 200-day simple moving average is 5.05, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a Sell
The current Dermata Therapeutics [DRMA] share price is $2.25. The Score for DRMA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
2.96M
Price in USD:
2.25
Share Volume:
580.63K
Dermata Therapeutics 52-Week Range
52-Week High:
17.25
52-Week Low:
1.29
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?
The Dermata Therapeutics stock price is 2.25 USD today. -
Will DRMA stock go up or go down?
Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Dermata Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is overvalued.
Is Dermata Therapeutics Stock a Buy?
- Dermata Therapeutics share price is 2.25 while DRMA 8-day exponential moving average is 1.91, which is a Buy signal.
- The stock price of DRMA is 2.25 while Dermata Therapeutics 20-day EMA is 1.85, which makes it a Buy.
- Dermata Therapeutics 50-day exponential moving average is 2.14 while DRMA share price is 2.25, making it a Buy technically.
- DRMA stock price is 2.25 and Dermata Therapeutics 200-day simple moving average is 9.07, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
- DRMA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Dermata Therapeutics is a Sell
- Dermata Therapeutics Relative Strength Index (RSI) is 58.02, which suggest Dermata Therapeutics is overbought
- The Bollinger Bands (25) for Dermata Therapeutics is (1.55 - 2.07), which suggest Dermata Therapeutics is a Sell
- The Bollinger Bands (100) for Dermata Therapeutics is (1.68 - 3.98), which suggest Dermata Therapeutics is a Sell
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.